OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
Lifang Zhou, Shaohua Yao
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 17
Lifang Zhou, Shaohua Yao
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 17
Showing 17 citing articles:
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 71
The future of rubber production: a review of genetic regulation of biosynthetic pathways and genome editing technologies in natural rubber-producing plants
Mohtaram Mahmoudieh, Parisa Jariani, Abbas Dehghan, et al.
Tree Genetics & Genomes (2025) Vol. 21, Iss. 2
Closed Access
Mohtaram Mahmoudieh, Parisa Jariani, Abbas Dehghan, et al.
Tree Genetics & Genomes (2025) Vol. 21, Iss. 2
Closed Access
Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 4
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
Aditya Sharma, Anil K. Giri
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 4
Aditya Sharma, Anil K. Giri
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 4
The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment
Yan Cheng, Haiyang Wang, Mo Li
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108524-108524
Closed Access | Times Cited: 11
Yan Cheng, Haiyang Wang, Mo Li
Journal of Diabetes and its Complications (2023) Vol. 37, Iss. 8, pp. 108524-108524
Closed Access | Times Cited: 11
Gene editing in common cardiovascular diseases
Anna-Maria Lauerer, Xurde M. Caravia, Lars S. Maier, et al.
Pharmacology & Therapeutics (2024), pp. 108720-108720
Open Access | Times Cited: 2
Anna-Maria Lauerer, Xurde M. Caravia, Lars S. Maier, et al.
Pharmacology & Therapeutics (2024), pp. 108720-108720
Open Access | Times Cited: 2
Integrating Artificial Intelligence and Advanced Genomic Technologies in Unraveling Autism Spectrum Disorder and Gastrointestinal Comorbidities: A Multidisciplinary Approach to Precision Medicine
Lama Ghunaim, Ahmed S.A. Ali Agha, Talal Aburjai
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 3, pp. 567-581
Closed Access | Times Cited: 2
Lama Ghunaim, Ahmed S.A. Ali Agha, Talal Aburjai
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 3, pp. 567-581
Closed Access | Times Cited: 2
Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical Use
Tiziana Montemurro, Cristiana Lavazza, Elisa Montelatici, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1066-1066
Open Access | Times Cited: 1
Tiziana Montemurro, Cristiana Lavazza, Elisa Montelatici, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1066-1066
Open Access | Times Cited: 1
Role of next‐generation sequencing in revolutionizing healthcare for cancer management
Om Saswat Sahoo, Hiya Aidasani, Arnab Nayek, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Om Saswat Sahoo, Hiya Aidasani, Arnab Nayek, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 4
Closed Access | Times Cited: 1
Prospects and challenges of CRISPR /Cas9 gene‐editing technology in cancer research
Ning Li, Jiahui Xi, Zi Yin, et al.
Clinical Genetics (2023) Vol. 104, Iss. 6, pp. 613-624
Closed Access | Times Cited: 4
Ning Li, Jiahui Xi, Zi Yin, et al.
Clinical Genetics (2023) Vol. 104, Iss. 6, pp. 613-624
Closed Access | Times Cited: 4
What's in a cure: designing a broad-spectrum HIV gene therapy
Rachel Berman, Will Dampier, Michael R. Nonnemacher, et al.
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 150-156
Open Access
Rachel Berman, Will Dampier, Michael R. Nonnemacher, et al.
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 3, pp. 150-156
Open Access
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
Akram Hosen, Md Nakibul Hasan Nishat, MD. Mohaimin Hossain Soaib, et al.
Nano Select (2024)
Open Access
Akram Hosen, Md Nakibul Hasan Nishat, MD. Mohaimin Hossain Soaib, et al.
Nano Select (2024)
Open Access
dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa
Qing Wang, Xiaoshu Xu, Siyu Chen, et al.
Science Advances (2024) Vol. 10, Iss. 51
Closed Access
Qing Wang, Xiaoshu Xu, Siyu Chen, et al.
Science Advances (2024) Vol. 10, Iss. 51
Closed Access
CRISPR-Cas-Mediated Optimization of Plant-Derived Natural Products of Biomedical Significance
A. Nair Asha, J Varjani Sunita
Reference series in phytochemistry (2024), pp. 1-40
Closed Access
A. Nair Asha, J Varjani Sunita
Reference series in phytochemistry (2024), pp. 1-40
Closed Access
CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC
Fabian Geyer, Maximilian Geyer, Ute Reuning, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Fabian Geyer, Maximilian Geyer, Ute Reuning, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL
A. R. Panda, S.R. Das
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 1-7
Open Access
A. R. Panda, S.R. Das
International Journal of Pharmacy and Pharmaceutical Sciences (2024), pp. 1-7
Open Access
Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR Cas9 mRNA LNPs
Chun‐Yu Chen, Xiaohe Cai, Barbara A. Konkle, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102383-102383
Closed Access
Chun‐Yu Chen, Xiaohe Cai, Barbara A. Konkle, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102383-102383
Closed Access
A Lipid Nanoparticle-Based Method for the Generation of Liver-Specific Knockout Mice
Sumiyo Morita, Takuro Horii, Mika Kimura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14299-14299
Open Access | Times Cited: 1
Sumiyo Morita, Takuro Horii, Mika Kimura, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14299-14299
Open Access | Times Cited: 1
